Business
Insilico Surges After Hong Kong IPO Amid AI Drugmaking Optimism
SOURCE:Bloomberg|BY:Sangmi Cha, Amber Tong
Artificial Intelligence drug discovery startup Insilico Medicine Cayman TopCo jumped 25% in its Hong Kong trading debut on Tuesday, capping a year of investor frenzy over China’s biotech and AI boom.
AI-biotechnology firm Insilico Medicine Cayman TopCo is set to debut in Hong Kong on Tuesday after raising $293 million in its initial public offering.